AI
ALZHEON, INC.
SEC filingBiotechnology · Framingham, MA
Amount raised$78.8Msold at filing
Total offering$500M$421.2M still open
Investors in the raise3count reported to the SEC
FiledSep 10, 2026first sale Aug 26, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher Noel DunnDirector
Neil W. FlanzraichDirector
Diane K. Jorkasky, M.D.Director
John K. Hey, Ph.D.Executive Officer
Susan K. Abushakra, M.D.Executive Officer
Muneer K. SatterDirector
Jordan W. HellerDirector
Aidan K. Power, MRCPsychExecutive Officer
Gino K. SantiniDirector
Kenneth K. MaceExecutive Officer
Martin Tolar, M.D., Ph.D.Executive Officer, Director
Adem K. AlbayrakExecutive Officer
Executive officers, directors and promoters as listed on the Form D.